Skip to main content
. 2018 Oct 5;1(6):e183115. doi: 10.1001/jamanetworkopen.2018.3115

Figure 3. Association of ZEB2 With Early Recurrence and Reduced Survival in the Validation Cohort.

Figure 3.

Kaplan-Meier survival curves for validation cohort demonstrating differences in overall survival (A) and disease-free survival (B) when patients were stratified as ZEB2 negative or positive. P values were calculated using the log-rank test.